Gram-negative Bacterial Infections
3 competing products in clinical development for Gram-negative Bacterial Infections.
Pipeline by Phase
Phase 23
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Cefiderocol + Standard of Care | Shionogi | Phase 2 | Completed | 35 |
| Cefiderocol + Standard of Care | Shionogi | Phase 2 | Completed | 35 |
| Cefiderocol + Standard of Care | Shionogi | Phase 2 | Completed | 35 |